Neurotoxicity De-Risking in Preclinical Drug Discovery

Our next generation NeuroDeRisk Toolbox contains a range of tools for screening chemical structures and drug candidates against a panel of neurotoxicophore models, able to identify compounds triggering molecular initiating events responsible for adverse outcomes. Using this tool in hit triaging, as well as in constant monitoring of your compounds evolving along the hit to lead and lead optimization phases, you will have a competitive edge with molecules less likely to fail in pre-clinical profiling and early clinical development. Include the tool via API in your compound registering system, allowing red-flagging of problematic molecules early on.